{"schema_version":"1","generated_at":"2026-11-05T09:05:48.392Z","data_as_of":"2026-11-03","url":"https://www.findmykol.com/kol/melissa-toyos","json_url":"https://www.findmykol.com/kol/melissa-toyos/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"melissa-toyos","name":"Melissa Toyos","credential":"MD","title":"Partner, Research Director, Facial Cosmetic Surgeon","specialty":"Ophthalmology","specialty_raw":"Ophthalmology","therapeutic_area":"Ophthalmology","therapeutic_areas":["Ophthalmology"],"institution":"Toyos Clinic","institution_url":"https://www.findmykol.com/institution/toyos-clinic","city":"Memphis","state":"TN","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1245223502","orcid":"0000-0003-4529-9643","openalex":"A5029544057"},"summary":"Melissa Toyos is Partner, Research Director, Facial Cosmetic Surgeon at Toyos Clinic. OpenAlex indexes 56 publications with 849 citations (h-index 14); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Melissa Toyos, MD, is Partner, Research Director, Facial Cosmetic Surgeon at Toyos Clinic. The public record shows 56 publications with 849 citations (h-index 14), centered on Ocular Surface and Contact Lens, Salivary Gland Disorders and Functions, Advanced Drug Delivery Systems. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 32 companies.","bullets":["Most recent indexed publication: 2026 · Patient preference and adherence","Top research focus: Ocular Surface and Contact Lens","5 registered trials on ClinicalTrials.gov","Open Payments reporting from 32 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"Inflammation","therapeutic_area":"Rheumatology/Immunology","trials":2,"topics":0,"strength":6},{"label":"Cataract","therapeutic_area":"Ophthalmology","trials":2,"topics":0,"strength":6},{"label":"Dry Eye / Uveitis","therapeutic_area":"Ophthalmology","trials":2,"topics":0,"strength":6},{"label":"Dry Eye Syndromes","therapeutic_area":"Ophthalmology","trials":2,"topics":0,"strength":6},{"label":"Pseudophakia","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Edema","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Papilledema","therapeutic_area":"Ophthalmology","trials":1,"topics":0,"strength":3},{"label":"Macular Degeneration (AMD)","therapeutic_area":"Ophthalmology","trials":0,"topics":0,"strength":1},{"label":"Glaucoma","therapeutic_area":"Ophthalmology","trials":0,"topics":0,"strength":1},{"label":"Atopic Dermatitis / Eczema","therapeutic_area":"Dermatology","trials":0,"topics":0,"strength":1}],"research_topics":["Ocular Surface and Contact Lens","Salivary Gland Disorders and Functions","Advanced Drug Delivery Systems","Ocular Infections and Treatments","Glaucoma and retinal disorders"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Acthar","generic":"Corticotropin","trials":0,"payments":417,"publications":3,"mentions":420},{"name":"Xiidra","generic":"Lifitegrast","trials":0,"payments":70,"publications":1,"mentions":71},{"name":"Oxervate","generic":"Cenegermin","trials":0,"payments":23,"publications":1,"mentions":24}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"Mallinckrodt Hospital Products Inc.","trials":0,"payments":412,"mentions":412},{"name":"Bausch & Lomb Americas Inc.","trials":0,"payments":165,"mentions":165},{"name":"Sun Pharmaceutical Industries Inc.","trials":0,"payments":164,"mentions":164}]}},"scholarship":{"works_count":56,"cited_by_count":849,"h_index":14,"i10_index":17,"pubmed_count":5,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07560735","title":"Clinical Evaluation of Lifitegrast Ophthalmic Solution 5.0% in Dry Eye Disease Using In Vivo Confocal Microscopy","phase":"PHASE4","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Toyos Clinic","source_url":"https://clinicaltrials.gov/study/NCT07560735","trial_url":"https://www.findmykol.com/trial/NCT07560735"},{"nct":"NCT03298841","title":"Clinical Comparison of Length of Cataract Procedures With Zeiss Lumera Versus Older Zeiss Microscope","status":"COMPLETED","role":"Investigator","sponsor":"Toyos Clinic","source_url":"https://clinicaltrials.gov/study/NCT03298841","trial_url":"https://www.findmykol.com/trial/NCT03298841"},{"nct":"NCT03287635","title":"Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease","phase":"PHASE4","status":"COMPLETED","role":"Investigator","sponsor":"Toyos Clinic","source_url":"https://clinicaltrials.gov/study/NCT03287635","trial_url":"https://www.findmykol.com/trial/NCT03287635"}],"source":"trials"},"payments":{"company_count":32,"program_years":{"first":2021,"last":2025},"rows_total":59,"shown":3,"withheld":56,"rows":[{"payer":"Mallinckrodt Hospital Products Inc.","program_year":2025,"amount_usd":107212.08,"payment_count":92,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245223502"},{"payer":"Bausch & Lomb Americas Inc.","program_year":2025,"amount_usd":58359.42,"payment_count":63,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245223502"},{"payer":"SUN PHARMACEUTICAL INDUSTRIES INC.","program_year":2025,"amount_usd":49074.53,"payment_count":61,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245223502"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1245223502","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":5,"shown":5,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Perspectives of Healthcare Professionals on the Treatment Landscape of Ocular Redness.","year":2026,"journal":"Patient preference and adherence","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41710338/","status":"verified"},{"title":"Evaluation of the Safety and Tolerability of Lumify Eye Illuminations Cosmetic Products.","year":2024,"journal":"Clinical ophthalmology (Auckland, N.Z.)","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39479552/","status":"verified"},{"title":"Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies.","year":2024,"journal":"Clinical ophthalmology (Auckland, N.Z.)","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39165367/","status":"verified"},{"title":"Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.","year":2022,"journal":"Clinical ophthalmology (Auckland, N.Z.)","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/36536927/","status":"verified"},{"title":"Management of repository corticotropin injection therapy for non-infectious uveitis: a Delphi study.","year":2021,"journal":"Acta ophthalmologica","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/33751822/","status":"verified"}],"most_cited":{"total":56,"shown":5,"withheld":51,"rows":[{"title":"Analysis of Cytokine Levels in Tears and Clinical Correlations After Intense Pulsed Light Treating Meibomian Gland Dysfunction","year":2017,"cited_by_count":215,"type":"article","source_url":"https://doi.org/10.1016/j.ajo.2017.08.021"},{"title":"Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes","year":2016,"cited_by_count":111,"type":"article","source_url":"https://doi.org/10.1097/ico.0000000000000940"},{"title":"Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study","year":2014,"cited_by_count":88,"type":"article","source_url":"https://doi.org/10.1167/iovs.13-12660"},{"title":"A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease","year":2018,"cited_by_count":73,"type":"article","source_url":"https://doi.org/10.2147/opth.s175065"},{"title":"Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study","year":2022,"cited_by_count":57,"type":"article","source_url":"https://doi.org/10.1371/journal.pone.0270268"}]},"source":"publications"},"network":{"coauthors_total":37,"shown":3,"withheld":34,"coauthors":[{"name":"Rolando Toyos","coauthored_works":12,"profile_url":"https://www.findmykol.com/kol/rolando-toyos"},{"name":"Melinda M DiVito","coauthored_works":6},{"name":"Jason Bacharach","coauthored_works":5,"profile_url":"https://www.findmykol.com/kol/jason-bacharach"}],"source":"works"},"presence":{"owned_accounts":{"total":2,"shown":2,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/melissa-toyos-md","status":"verified"},{"platform":"linkedin","url":"https://www.linkedin.com/in/melissa-toyos-19056372","status":"provisional"}]},"mentions":{"total":5,"shown":3,"rows":[{"url":"https://podcasts.apple.com/us/podcast/womens-hair-loss-breakthroughs-red-light-fue-brows/id1787936833?i=1000773344308&uo=4","platform":"apple_podcasts","status":"provisional"},{"url":"https://ophthalmology360.com/advisoryboard/melissa-toyos/","platform":"other","status":"provisional"},{"url":"https://toyos-clinic.myshopify.com/pages/about-us","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"MD","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"},{"value":"Board-certified ophthalmologist","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"},{"value":"Summa Cum Laude graduate of Louisiana State University","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"President, Missouri Society of Eye Physicians and Surgeons","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"},{"value":"Deputy Section Leader, American Academy of Ophthalmology","source_url":"https://toyos-clinic.myshopify.com/pages/about-us","status":"provisional","collected_at":"2026-11-04"}]},"awards":{"total":6,"shown":3,"rows":[{"value":"Lieberman Award","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"},{"value":"Harold Stein and Earl Young Awards","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"},{"value":"ASCRS Research Grants","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Co-founder, Toyos Foundation","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"}]},"media":{"total":4,"shown":3,"rows":[{"value":"Podcast episode, The Bougie Baldie Podcast: Women’s Hair Loss Breakthroughs: Red Light, FUE Brows/Beard, JAK Inhibitors & Vortiporfin (Dr. Melissa Toyos)","source_url":"https://podcasts.apple.com/us/podcast/womens-hair-loss-breakthroughs-red-light-fue-brows/id1787936833?i=1000773344308&uo=4","status":"provisional","collected_at":"2026-11-04"},{"value":"YouTube video: Dry Eye Gets Personal (Rolando Toyos, MD & Melissa Toyos, MD)","source_url":"https://www.youtube.com/watch?v=TZ1IIqID9D0","status":"provisional","collected_at":"2026-11-04"},{"value":"YouTube video: Dr. Melissa Toyos- Verteporfin is a GAME CHANGER!","source_url":"https://www.youtube.com/watch?v=8K6MtXCKlTI","status":"provisional","collected_at":"2026-11-04"}]},"public_positions":{"total":3,"shown":2,"rows":[{"value":"National director of research and training, SmartGraft / SmartSolutions automated hair restoration system","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"},{"value":"Frequent lecturer at AAO, ASCRS, and ARVO","source_url":"https://www.toyosclinic.com/md/melissa-toyos-md","status":"verified","collected_at":"2026-11-04"}]}},"similar":[{"name":"Rolando Toyos","slug":"rolando-toyos","institution":"Toyos Clinic","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/rolando-toyos","json_url":"https://www.findmykol.com/kol/rolando-toyos/profile.json"},{"name":"Robert Weinreb","slug":"robert-weinreb","institution":"University of California San Diego","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/robert-weinreb","json_url":"https://www.findmykol.com/kol/robert-weinreb/profile.json"},{"name":"Emily Chew","slug":"emily-chew","institution":"National Eye Institute","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/emily-chew","json_url":"https://www.findmykol.com/kol/emily-chew/profile.json"},{"name":"Harry Quigley","slug":"harry-quigley","institution":"Johns Hopkins University School of Medicine","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/harry-quigley","json_url":"https://www.findmykol.com/kol/harry-quigley/profile.json"},{"name":"Joel Schuman","slug":"joel-schuman","institution":"Wills Eye Hospital","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/joel-schuman","json_url":"https://www.findmykol.com/kol/joel-schuman/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":56,"network":34}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-04"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-04"}},"methodology_url":"https://www.findmykol.com/about#methodology"}